SAMHD1 is a Novel Biomarker and Therapeutic Target for Radiation Therapy and PARP Inhibition

被引：0
|
作者：
Schlafstein, A. [1 ]
Daddacha, W. [1 ]
Kowalski, J. [1 ]
Yu, D. S. [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
P86
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] SAMHD1 is a Novel Biomarker and Therapeutic Target for Radiation Therapy and PARP Inhibition in Breast Cancer
    Thompson, Elizabeth
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Targeting a Novel Function for SAMHD1 in DNA Repair for Radiation Therapy and PARP Inhibition
    Yu, D.
    Daddacha, W.
    Koyen, A.
    Bastien, A.
    Head, P.
    Dhere, V.
    Nabeta, G.
    Connolly, E.
    Werner, E.
    Madden, M.
    Daly, M.
    Minten, E.
    Whelan, D.
    Zhang, H.
    Anand, R.
    Shepard, C.
    Sundaram, R.
    Deng, X.
    Dynan, W.
    Wang, Y.
    Bindra, R.
    Cejka, P.
    Rothenberg, E.
    Doetsch, P.
    Kim, B.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S192 - S193
  • [3] SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
    Constanze Schneider
    Thomas Oellerich
    Hanna-Mari Baldauf
    Sarah-Marie Schwarz
    Dominique Thomas
    Robert Flick
    Hanibal Bohnenberger
    Lars Kaderali
    Lena Stegmann
    Anjali Cremer
    Margarethe Martin
    Julian Lohmeyer
    Martin Michaelis
    Veit Hornung
    Christoph Schliemann
    Wolfgang E Berdel
    Wolfgang Hartmann
    Eva Wardelmann
    Federico Comoglio
    Martin-Leo Hansmann
    Alexander F Yakunin
    Gerd Geisslinger
    Philipp Ströbel
    Nerea Ferreirós
    Hubert Serve
    Oliver T Keppler
    Jindrich Cinatl
    Nature Medicine, 2017, 23 : 250 - 255
  • [4] SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
    Schneider, Constanze
    Oellerich, Thomas
    Baldauf, Hanna-Mari
    Schwarz, Sarah-Marie
    Thomas, Dominique
    Flick, Robert
    Bohnenberger, Hanibal
    Kaderali, Lars
    Stegmann, Lena
    Cremer, Anjali
    Martin, Margarethe
    Lohmeyer, Julian
    Michaelis, Martin
    Hornung, Veit
    Schliemann, Christoph
    Berdel, Wolfgang E.
    Hartmann, Wolfgang
    Wardelmann, Eva
    Comoglio, Federico
    Hansmann, Martin-Leo
    Yakunin, Alexander F.
    Geisslinger, Gerd
    Stroebel, Philipp
    Ferreiros, Nerea
    Serve, Hubert
    Keppler, Oliver T.
    Cinatl, Jindrich, Jr.
    NATURE MEDICINE, 2017, 23 (02) : 250 - 255
  • [5] Interaction Between Vpx and SAMHD1, Vital for SAMHD1 Inhibition
    Hasanshahi, Zahra
    Dehghani, Behzad
    Hashempour, Ava
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (06) : 384 - 392
  • [6] Correction: Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
    Constanze Schneider
    Thomas Oellerich
    Hanna-Mari Baldauf
    Sarah-Marie Schwarz
    Dominique Thomas
    Robert Flick
    Hanibal Bohnenberger
    Lars Kaderali
    Lena Stegmann
    Anjali Cremer
    Margarethe Martin
    Julian Lohmeyer
    Martin Michaelis
    Veit Hornung
    Christoph Schliemann
    Wolfgang E Berdel
    Wolfgang Hartmann
    Eva Wardelmann
    Federico Comoglio
    Martin-Leo Hansmann
    Alexander F Yakunin
    Gerd Geisslinger
    Philipp Ströbel
    Nerea Ferreirós
    Hubert Serve
    Oliver T Keppler
    Jindrich Cinatl
    Nature Medicine, 2017, 23 : 788 - 788
  • [7] SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia (vol 23, pg 250, 2017)
    Schneider, Constanze
    Oellerich, Thomas
    Baldauf, Hanna-Mari
    Schwarz, Sarah-Marie
    Thomas, Dominique
    Flick, Robert
    Bohnenberger, Hanibal
    Kaderali, Lars
    Stegmann, Lena
    Cremer, Anjali
    Martin, Margarethe
    Lohmeyer, Julian
    Michaelis, Martin
    Hornung, Veit
    Schliemann, Christoph
    Berdel, Wolfgang E.
    Hartmann, Wolfgang
    Wardelmann, Eva
    Comoglio, Federico
    Hansmann, Martin-Leo
    Yakunin, Alexander F.
    Geisslinger, Gerd
    Strobel, Philipp
    Ferreiros, Nerea
    Serve, Hubert
    Keppler, Oliver T.
    Cinatl, Jindrich, Jr.
    NATURE MEDICINE, 2017, 23 (06) : 788 - 788
  • [8] PARP1 INHIBITION AS A NOVEL THERAPEUTIC TARGET FOR KELOID DISEASE
    Park, Tae Hwan
    Park, Yun Joo
    WOUND REPAIR AND REGENERATION, 2019, 27 (03) : A40 - A40
  • [9] PARP1 Inhibition as a Novel Therapeutic Target for Keloid Disease
    Park, Tae Hwan
    Kim, Chan Woo
    Choi, Jin Sik
    Park, Yun Joo
    Chong, Yosep
    Park, Min Ji
    Cho, Yuri
    ADVANCES IN WOUND CARE, 2019, 8 (05) : 186 - 194
  • [10] Inhibition of Hepatitis B virus replication by SAMHD1
    Chen, Zhangming
    Zhu, Mengying
    Pan, Xiang
    Zhu, Yongji
    Yan, Hai
    Jiang, Tongcui
    Shen, Yujun
    Dong, Xiaowan
    Zheng, Nan
    Lu, Jinsen
    Ying, Songcheng
    Shen, Yuxian
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 450 (04) : 1462 - 1468
12345